ARQ Wealth Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
ARQ Wealth Advisors's PPH Position: Q3 2026 in Review
ARQ Wealth Advisors increased its VanEck Pharmaceutical ETF (PPH) stake by 7.2% in Q3 2026, buying an estimated $85.7K and bringing the position to 11,443 shares worth $1.25M. The position accounts for 0.15% of the portfolio, ranked #110.
ARQ Wealth Advisors first reported a position in PPH in Q1 2026 and has held it in 3 quarters since. 156 funds tracked by Wall St. Rank hold PPH as of Q3 2026.
- ARQ Wealth Advisors held 11,443 shares of VanEck Pharmaceutical ETF worth $1.25M as of Q3 2026.
- ARQ Wealth Advisors bought 769 VanEck Pharmaceutical ETF shares in Q3 2026, an estimated $85.7K.
- VanEck Pharmaceutical ETF made up 0.15% of ARQ Wealth Advisors's portfolio in Q3 2026, its #110 holding.
- ARQ Wealth Advisors first reported a position in VanEck Pharmaceutical ETF in Q1 2026 and has held it in 3 quarters since.
- 156 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.
Based on ARQ Wealth Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.